§ BIOTECHNOLOGY
USD · Biotechnology

IRWD

IRONWOOD PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.22
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
103 increased/new, 84 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E6.3P/B2.91
EPS (TTM)0.58
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
ARMISTICE CAPITAL, LLC15.0M0.9%−6%
BlackRock, Inc.13.4M0.0%+5%
Sarissa Capital Management LP9.2M20.5%−42%
Bank of America Corp8.7M0.0%−25%
Renaissance Technologies8.1M0.0%−2%
AQR Capital Management7.5M0.0%+60%
◇ AC INTELLIGENCE

Top institutional owners for IRWD as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER71.8% · 0 holders
OTHER14.3% · 155 holders
DEALER / BANK5.6% · 22 holders
PASSIVE / INDEX3.7% · 9 holders
SYSTEMATIC / QUANT2.7% · 9 holders
QUALITY / COMPOUNDER1.6% · 16 holders
INCOME / DEFENSIVE0.2% · 9 holders
TACTICAL / MACRO0.1% · 2 holders
GROWTH / MOMENTUM0.0% · 1 holder
DEEP VALUE0.0% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for IRWD in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention IRWD yet.